Inogen (INGN) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Inogen (INGN) has outperformed Quanterix (QTRX) over the past year, losing 31.6% versus a loss of 46.5%. Over five years, INGN leads with a -85.4% price change compared with -93.8% for QTRX. Inogen is the larger company by market cap ($162.8 million vs $156.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INGN | QTRX |
|---|---|---|
| Share price | $6.14 | $3.31 |
| Market cap | $162.81M | $156.30M |
| 1-day change | +3.28% | +2.96% |
| YTD return | -11.61% | -49.53% |
| 1-year return | -31.65% | -46.50% |
| 5-year return | -85.45% | -93.79% |
| EPS (TTM) | $-0.92 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.13 | $8.77 |
| 52-week low | $5.05 | $2.15 |
| Distance from 52-week high | -32.80% | -62.31% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +95.60% | -9.23% |
| Average volume | 294.94K | 764.39K |
| Shares outstanding | 26.54M | 47.29M |
| Employees | 753 | 450 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INGN has outperformed QTRX by 14.9 percentage points over the past year.
- The two companies sit in different sectors: Inogen in Health Care and Quanterix in Industrials.
About Inogen
INGN stock →Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Health Care · Industrial Specialties · 753 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
INGN vs QTRX FAQ
Which is bigger, Inogen or Quanterix?
Inogen (INGN) is larger, with a market capitalization of $162.81M compared with $156.30M for Quanterix (QTRX).
Which stock has performed better over the past year, INGN or QTRX?
INGN returned -31.65% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Inogen and Quanterix in the same industry?
No. Inogen is in the Health Care sector, while Quanterix is in Industrials.